WOBURN – October 30, 2026 -- Cytrellis Biosystems will supply its ellacor system and clinical educators to all three annual cohorts of the University of Miami's 12-week Aesthetic Medicine Certificate Program, under a partnership with the Academy for Aesthetics and Anti-Aging Studies (AFAAAS).

Woburn, Mass. – – September 29, 2026 -- Cytrellis Biosystems, Inc. has signed a commercialization agreement with KoreAx Co. Ltd. to launch its ellacor skin-removal device in South Korea, marking the company's second international market entry of 2026 after Australia.